Variant report
Variant | nsv877242 |
---|---|
Chromosome Location | chr3:103095170-103140700 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs566719243 | chr3:103104811-103104812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs534069735 | chr3:103104839-103104840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs553448586 | chr3:103104879-103104880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs568439884 | chr3:103104930-103104931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs535986769 | chr3:103104960-103104961 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs10804921 | chr3:103104977-103104978 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
7 | rs144581469 | chr3:103105010-103105011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs75857438 | chr3:103105011-103105012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs546334559 | chr3:103105046-103105047 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs193092839 | chr3:103105076-103105077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs573243113 | chr3:103105091-103105092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540521986 | chr3:103105097-103105098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs74680010 | chr3:103105155-103105156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs528844047 | chr3:103105159-103105160 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs543993289 | chr3:103105186-103105187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs562555722 | chr3:103105187-103105188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs532991315 | chr3:103105208-103105209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs146698394 | chr3:103105283-103105284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs72966293 | chr3:103105295-103105296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs75521331 | chr3:103105296-103105297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs549281136 | chr3:103105322-103105323 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs59115464 | chr3:103105342-103105343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs10804922 | chr3:103105406-103105407 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs148838826 | chr3:103105449-103105450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs185288252 | chr3:103105477-103105478 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs569296476 | chr3:103105505-103105506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs112383031 | chr3:103106451-103106452 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs116492868 | chr3:103106479-103106480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs551483740 | chr3:103106493-103106494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs566585299 | chr3:103106514-103106515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs534017595 | chr3:103106527-103106528 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs74990109 | chr3:103106538-103106539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs143016640 | chr3:103106539-103106540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs538562138 | chr3:103106542-103106543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs537185701 | chr3:103106550-103106551 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs556543190 | chr3:103106559-103106560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs577586279 | chr3:103106563-103106564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs558683628 | chr3:103106592-103106593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs538589872 | chr3:103106605-103106606 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs372527132 | chr3:103106616-103106617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs79483822 | chr3:103106632-103106633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs111876934 | chr3:103106652-103106653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs576964407 | chr3:103106715-103106716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs369560037 | chr3:103106741-103106742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs147446477 | chr3:103106811-103106812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs139308035 | chr3:103106835-103106836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs534438451 | chr3:103106929-103106930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs543717614 | chr3:103106936-103106937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs554511682 | chr3:103106996-103106997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs552896060 | chr3:103107041-103107042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:103104800-103105400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr3:103105000-103105600 | Enhancers | Fetal Brain Male | brain |
3 | chr3:103106400-103107400 | Enhancers | Colon Smooth Muscle | Colon |
4 | chr3:103106800-103107600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr3:103106800-103107800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
6 | chr3:103107000-103107400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
7 | chr3:103107000-103107600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
8 | chr3:103107000-103107600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr3:103107200-103107400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr3:103107400-103107600 | Enhancers | Fetal Brain Male | brain |
11 | chr3:103107800-103112200 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
12 | chr3:103112200-103113200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
13 | chr3:103112600-103113200 | Enhancers | NH-A | brain |
14 | chr3:103121200-103122400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
15 | chr3:103121800-103122600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
16 | chr3:103128800-103129200 | Bivalent Enhancer | ES-WA7 Cell Line | embryonic stem cell |